Natural history of CKD stage 4 and 5 patients following referral to renal management clinic

International Urology and Nephrology

Volumn 41, Issue 4, 2009, Pages 977-982

  Zhang, Ai Hua ^a   Tam, Paul ^b   Leblanc, Denise ^b   Zhong, Hui ^c   Chan, Christopher T ^d,e   Bargman, Joanne M ^d,e   Oreopoulos, Dimitrios G ^d,e  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b SCARBOROUGH HOSPITAL   (Canada)

^c SICHUAN UNIVERSITY   (China)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Chronic kidney disease; Course analysis; EGFR; Renal management clinic

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; ARTICLE; CANADA; CHRONIC KIDNEY DISEASE; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEALTH CARE FACILITY; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT REFERRAL;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CHINA; COHORT STUDIES; CREATININE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FUNCTION TESTS; LOGISTIC MODELS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MULTIVARIATE ANALYSIS; REFERRAL AND CONSULTATION; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 77954563153     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9604-3     Document Type: Article

References (19)

1. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS (2003) Prevalence of chronic kidney disease and decreased kidney function in the adult us population: third national health and nutrition examination survey. Am J Kid Dis 41:1-12
2. De Vecchi AF, Dratwa M, Wiedermann ME (1999) Healthcare systems and ESRD therapies-an international review. Costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant 14(Suppl 6):31-41
3. Zhou XJ, Saxena R, Liu ZH, Vaziri ND, Silva FG (2008) Renal senescence in 2008: progress and challenges. Int Uro Nephrol 40:823-839
4. United States Renal Data System (USRDS) (2003) USRDS annual report: incidence and prevalence of ESRD. Am J Kid Dis 42(Suppl 5):1-230
5. K/DOQI clinical practice guidelines for chronic kidney disease (2002) Evaluation classification and stratification kidney disease outcomes quality initiative. Am J Kid Dis 39(Suppl 2):S7-S246
6. Jones C, Roderick P, Harris S, Rogerson M (2006) Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Nephrol Dial Transplant 21:2133-2143
7. Van Biesen W, Vanholder R, Veys N, Verbeke F, Delanghe J, De Bacquer D et al (2006) The importance of standardization of creatinine in the implementation of guidelines and recommendations for CKD: implications for CKD management programmes. Nephrol Dial Transplant 21(1):77-83 Epub 2005 Oct 12
8. Taskapan H, Tam P, Au V, Chow S, Fung J, Nagai G et al (2008) Improvement in eGFR in patients with chronic kidney disease attending a nephrology clinic. Int Urol Nephrol Epub 40:841-848. doi:10.1007/s11255-008-9360-9
9. Mendelssohn DC, Toffelmire EB, Levin A (2006) Attitudes of Canadian nephrologists towards multidisciplinary team-based CKD clinic care. Am J Kidney Dis 47:277-284
10. Levin A, Djurdjev O, Beaulieu M, Er L (2008) Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis 52(4):661-671
11. Lindeman RD (2007) Hypertension and kidney protection in the elderly: what is the evidence in 2007? Int Urol Nephrol 39:669-678
12. Johnson ES, Thorp ML, Platt RW, Smith DH (2008) Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study. Am J Kidney Dis 52:653-660 Epub 2008 Jun 30
13. Pohl MA, Blumenthal S, Cordonnier DJ, De Alvaro F, Deferrari G, Eisner G et al (2005) Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the Irbesartan diabetic nephropathy trial: clinical implications and limitations. J Am Soc Nephrol 16:3027-3037
14. Covic A, Gusbeth-Tatomir P, Goldsmith DJ (2007) Current dilemmas in inhibiting the renin-angiotensin system: do not forget real life. Int Urol Nephrol 39:571-576
15. Hou FF, Zhang X, Zhang GH, Xie D, Chen PY, Zhang WR et al (2006) Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med 354(2):131-140
16. Tseng CL, Elizabeth FOK, Miller DR, Tiwari A, Maney M, Rajan M, Pogach L (2008) Survival benefit of nephrologic care in patients with diabetes mellitus and chronic kidney disease. Arch Intern Med 168(1):55-62
17. Tattersall J, Martin-Malo A, Pedrini L, Basci A, Canaud B, Fouque D et al (2007) EBPG guideline on dialysis strategies. Nephrol Dial Trans 22(2):5-21
18. Fouque D, Guebre-Egziabher F (2007) An update on nutrition in chronic kidney disease. Int Uro Nephrol 39: 239-246 (Pubitemid 46722972)
19. Ersoy FF (2007) Osteoporosis in the elderly with chronic kidney disease. Int Uro Nephrol 39:321-331